Taketoshi Furugohri

DU‐176b, a potent and orally active factor Xa inhibitor: in vitro and in vivo pharmacological profiles

Taketoshi Furugohri, K. Isobe, Yuko Honda et al. · Journal of Thrombosis and Haemostasis · 2008 · 300 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +5

Antithrombin-independent thrombin inhibitors, but not direct factor Xa inhibitors, enhance thrombin generation in plasma through inhibition of thrombin-thrombomodulin-protein C system

Nobutoshi Sugiyama, Y Morishima, Toshiro Shibano et al. · Thrombosis and Haemostasis · 2011 · 59 citations

Medicine, Hematology, Pharmacology +17

Different antithrombotic properties of factor Xa inhibitor and thrombin inhibitor in rat thrombosis models

Taketoshi Furugohri, Yoko Shiozaki, Sumie Muramatsu et al. · European Journal of Pharmacology · 2005 · 40 citations

Medicine, Medicinal Chemistry, Pharmacology +15

The effects of warfarin and edoxaban, an oral direct factor Xa inhibitor, on gammacarboxylated (Gla-osteocalcin) and undercarboxylated osteocalcin (uc-osteocalcin) in rats

Y Morishima, Chikako Kamisato, Yuko Honda et al. · Thrombosis Research · 2012 · 34 citations

Medicine, Pharmacokinetics, Pharmacology +9

Cycloalkanediamine derivatives as novel blood coagulation factor Xa inhibitors

Tsutomu Nagata, Toshiharu Yoshino, Noriyasu Haginoya et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 33 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11